𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Influence of thymidylate synthase and p53 protein expression on clinical outcome in patients with colorectal cancer

✍ Scribed by R. Broll; P. Busch; M. Duchrow; E. Oevermann; O. Schwandner; S. Farke; H. P. Bruch; U. Windhövel

Publisher
Springer
Year
2004
Tongue
English
Weight
380 KB
Volume
20
Category
Article
ISSN
0179-1958

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topoisomerase-I, thymidylate synthase pr
Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients
✍ Angelo Paradiso; JanMing Xu; Anita Mangia; Annalisa Chiriatti; Gianni Simone; Al 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 229 KB

## Abstract While several studies have reported that thymidylate synthase (TS) tumour expression can be a reliable predictive marker of clinical response to 5‐Fluorouracil (5‐FU) for advanced colorectal cancer patients, only a few studies that searched for predictive factors of irinotecan (CPT‐11)

Prognostic significance of cyclooxygenas
Prognostic significance of cyclooxygenase-2 expression and nuclear p53 accumulation in patients with colorectal cancer
✍ Sung-Chul Lim; Tae-Bum Lee; Cheol-Hee Choi; So-Yeon Ryu; Young-Don Min; Kyung-Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

## Abstract ## Background Cyclooxygenase (COX)‐2 is believed to be an important enzyme related to the pathogenesis of colorectal cancer (CRC). p53 has been reported to be a negative regulator of COX‐2 expression in in vitro studies. The aim of this study was to investigate COX‐2 expression and its